No I mean 1.5M. I've never aquired so much at once.

Help!

Sorry to be asking you for advice in a public forum (sadly, I haven't upgraded)..here it comes... but!

I'm trying to fill a huge order but it was moving the sp, of course, but is the correct strategy to raise my bid?

I'm at .26 but didn't raise it to .28. I plan to leave it at .26 for the open.. unless I get guidance from you, or the board.

I'm not trying to move the sp to unrealistic levels but it seems doable, as I have 1.5 still to fill.

Thanks, and sorry..again.

My boat overflow(ith)!

Fuel the Rocket Smoki!

Are you sure GMoney? Lol

Sorry, I just made a proposal to the group I represent.

We have put in an order at .26 for 1.94M shares.

Lawd help me! What have I gotten myself into here! Sorry that was rhetorical, no response needed (eom) haha.. just venting.. or hyperventilating..not sure anymore.

Good Luck Algernaut's!!

LS5

..You're a funny guy LMAO

All very solid points, preaching to the choir.

Although the 2 big player's you mentioned, Draeger and Lifeloc, we're names tossed around in 2016. Still watching from the sidelines for good reason, imo. The goal is clear, recency of use, but getting there is clearly a task of great difficulty.

I invested here because they had, at least what I believed to be, 3rd party validation in regards to Dr Yost and his track record with U of Florida.

...And they were they only publicly traded stock in the space at the time, and still are, for all I know, which isn't much.

I have nothing left either but some left over scraps... just in case.

The acceleration from a triple-qudrapole mass spectrometer the size of a small pick-up truck, reduced in Beta ?.? To "desktop" size, sent this to "15 bagger land". This is where I would love to say I sold. Sadly I hung around too long, took half of what I could've, but over 700% gain.

No complaints from me on this play. But as for a company... been led astray too many times.

Quote: "EOM"

Followed by a reply.

Quote: "Weak hands tend to have more questions"

Followed by another question.

This is solid comedy..You can't make this shit up..lol.

LS5

Even "He who's name I shall not speak" will not be able to manipulate the 100M+ volume days that are coming.

Black Friday Buying Opportunities.

Still my advice.. two words.. roll1, relax. Ok maybe 3 words... whatever.

...Commence Countdown.

LS5

Yes I agree, "recency of use" is the target. It has proven to be elusive.

As a frequent poster here once posited.. (in summary) there's a reason why the other big player's haven't put any effort into this "fool's errand".

The time for playing BLOZF was a couple years ago, when an "emoty box" could run the sp to near $3...imo

Anyway! Good luck!

LS5

Testing for THC impairment is impossible.

Mostly because a guy doesn't get progressively high the more he smokes, like alcohol, where you can drink yourself into a blackout, or worse, death, reletively quick. You'll never get "blacked out" smoking weed. Trust me, been testing both theories extensively for 30yrs.

It's like chasing rainbows and unicorns.

The "Orient"...lol

Damn not that "old school".. and not very PC.

Anyway.. Ifenprodil will make vaccines immaterial.

A proven therapeutic, with the safety record our little gem has, will gain the trust of ant-vaxxers, anti-they-gonna-chip-me's,..etc.

And let's not forget the whole group of people who usually vax, but don't trust a "rushed" vaccine.

No worries here.

LS5

So many questions I'm sorry that we must endure... when will we reach full enrollment? How long before we get complete data results? When will the Phase3 begin?

Don't know and it doesn't matter.

Only The Powers That Be hold our answers. And there will not be any warning when they arrive.
AC/DC - Thunderstruck (Official Video) / acdcVEVO

Not necessarily. Interim data is being compiled and analyzed for a stated release 1st week of December.

The full release of completed trial data will be 2 months after last patient dosed. Two weeks treatment, 2 weeks follow-up, and then a month to compile the data and digest it.

Interim data is coming long before the complete trial data is known because THEY ALREADY KNOW IT WORKS!, imo. (Sorry for shouting).

Either that or they just committed to a partial readout where anything but overwhelming positive data will be a non-issue and irrelevant to investor confidence.

Share price suicide.

I will stay confident our good Dr Williams did not "jump the shark" and take a "shot in the dark" with interim data, without already knowing.

Stop! Stop! Please! I beg of you!

I just needed a little Cold Compress after a Bunion appeared on my big toe of optimism.

But you went and worked me up to a frenzy over here.. with all those $ signs sprinkeld in.

Hold up, I take it all back. A 3+ year track record of DD supported (much thanks btw) straight dope will soon be verified. Well done Sir.

In fact, straight dope is exactly what I needed.

And just what the good Dr Feelgood (aka M$)(aka AMuthaf'nG)(aka G$) ordered.

...You know us Americans and our pills.

Good Luck Algernaut's!!

LS5

Now there's the spirit!

And what does it matter anyways, at this point, when an answer to all of the questions is only a few weeks away?

Keep hope alive!

Serious question... is GVX808 your license plate #? Lol jk

Just a little harmless teasing amongst the Algernaut's!

Good luck with the Lambo SnagWagon!

LS5

Serious question from a greenhorn..

I/we have been thru a reverse-split. What are the chances of a forward-split? (My phone had "reverse-split" in it's text memory, but I had to type the entire "forward-split".. twice now. Lol)

Please disregard if you feel this question is "too soon".

There I go.. jinxed everything..*crying emoji here*

PS.. Pac and Nas? Datswassup sir.

Challenge! 18 holes, 100 shares (pps on Jan.1st) AGNPF/hole. ??

LS5

The market shall decide.

But it should be noted that, while devastating, a perfect storm is developing with a peak hitting around data results announcement.

Could set off a buying frenzy itself. I expect (bias alert!) to see north of $1 before data release.

Decidedly positive data will be a "fuel the rocket scenario". Remember the sister hit nearly $3/share (although better share structure, I think), with absolutely Zero substance.

Marginal efficacy will result in a slightly over-baked-in price and will see a "sell the news" scenario.

Poor results... well I prefer to not even discuss that scenario.

Good luck to the Algernaut's!

Before our resident expert weighs in on this question, let me take a crack at it.

I would agree with Medchem. End of story..lol.

Ok seriously, other then the news about Phizer's vaccine, which has been said all along has it's own issues with efficacy to the masses, as well as a potentially mutating virus which could render it obsolete. But maybe most relevant, the trust factor with 50% of the US population surveyed as "don't trust it, or any vaccines".

Let's also remember what CJM stated, there will "always be a need for therapeutics". They are not in competition with eachother.

Let's also not forget! Ifenprodil has shown potential to reverse the lung damage already suffered by those infected and since recovered.

As for therapeutics? I'm not aware of any, at least in our class, that are potentially "stealing our thunder". There is the antibody treatment, which is cost prohibitive to most, and a logistics challenge to distribute.

To think, after all of this time, Algernon would "Jump the Shark" so close to a full trial data readout, is illogical to me.

Just my take on things, nothing expert about it in the least.

But Smoki is right!

Roll 1 up and chill... the only clinically tested and data proven Modus Operandi here at Algernon.

LS5

Yea, masks are pointless!

Ask any medical expert.

Well, not the one's that use them for surgeries.

Or any Infectious disease experts.

Ok.. maybe only Dr. Dre or Doctor J.

Helpful Hint...

ALL CAPS IS ANNOYING AF.

...in my opinion.

Seems to be missing the "2B/" in front of the "3".

The author may have just come out of long-term hibernation... Or inebriation. Hard to tell.

I believe it was stated in the mist recent update that many factors could slow the rate of enrollment.

The screening process involves finding patients hospitalized and using oxygen. So the process is limited to specific conditions.

It was also stated that many patients are showing up to the hospital at an advanced stage of infection, past the point of receiving the doses by pill.

At some point, with positive data, the company (or whichever Big Pharma company that has licensing rights/ownership) will finish the work started on an intravenous form of Ifenprodil.

One other tidbit from the update.. Chris mentioned the potential of a backlog of recording data from each patient, and how intensive that collection process is. Also mentioned how the doctor's control the study, not the company.

Food for thought...In my opinion only.

Patience has always been, and remains, the best modus operandi to follow here at Algernon.

But besides that, the company and especially Chris and Mark, the 2-Man Wrecking Crew of hitting milestones and deadlines...so far... shouldn't be 2nd guessed and Monday Morning Quarterbacked just yet.

The damn game is only getting started.

And to borrow a term that is needed here to finish up...Sheesh!

Good Luck and keep your head up! The punches never stop comin around here.

But like The Greatest... the Rope-a-dope strategy has worked before. We're not out of this fight one bit!

Algernon Boom By Yay!

LS5

LS5

Not sure why this convo was necessary but here we are.. again.

AMG... you are correct, again. It's like Dèjá Vu.

Only thing I will add is the progression to Phase3 is meaningless, either way.. good results, marginal efficacy, or worse.

With positive data, an EUA will be granted and we are on the big boys' radar. Buyout/licensing will be imminent. Although the bigger Phase3 will happen, it's Game over, we win.

The reason why this convo is meaningless, you ask?

The MF trial enrollment is 90-somn damn % done. The finish line is in sight, almost.

As a guy with Yuge power (reasons unknown/unbelievable) has stated (well, erroneously on another subject).. "we are rounding the corner"!

And one more thing... to those not named AMG and others here from time immemorial...

Any, and all PR's will amount to nothing until efficacy is established. (Add emphasis here).

Good Luck! The moment we've all been waiting for is 2 months away. The excitement is worth all of the frustration, IMO only.

LS5

WTF?

Not great news, just confirming what the company has stated and shown us.

Ifenprodil is a 50yr old drug that has a documented safety history.

Nothing should be construed as "proven efficacy" in today's PR, only confirming what we already knew, which is a good thing.

LS5

"Remember Red... hope is a good thing, maybe the best of things. And no good thing ever dies"

.. Andy Dufresne.

Well it seems we have both missed eachother's point.

My long-winded version seems to have only caused confusion.

So.. to be short, and to "the point".

Any, and all, PR's to date have been meaningless to the SP.

My advise.. roll 1, relax, resume our convo after the CEO gives his update tomorrow.

Good Luck G! We're all on the same team here.

LS5

As someone guilty of "word overload" at times, I take no small offense to your comment.

Lol.

Anyways.. you seem to have cooked up your own bowl of alphabet soup, that nobody was hungry for.

Lol.

What I mean is.. why TF (pardon my French) would we/anyone need to be told of a 90% milestone (I use this word very looey here), when Egg Zach Lee Zero of the previous updates have garnered a single bit of traction? Aside from the fact that an announcement with only 15 patients left.. is nothing more then a "penultimate piss-off" moment. Another PR in the 2yr abyss of worthless PR's to chap our hide, one last time.

I, for one, think your post was a day early.

Like.. you couldn't wait until after the day they plan to update shareholder's?

But.. have at 'em.

I will patiently continue to wait on real updates.

Its All About The Data! The Data! The Data!

At ease.. and carry on.

LS5

Article appeared to written by a 3rd grader.

Confusing AF.

Not sure that analysis holds much relevance.

For all we know, the spraying/fogging might be preventing an even bigger spike.

One is not indicative of the other, imo.

...Just sayin.

*dolla.. lol

Lol my story is much sadder.

Took a 50% haircut during The Great Depression (reverse-split).

PS...

It's like they know my average sp is $.27. It never gets above..lol

Yes, well, it's a little nerve-wracking to have "anticipated timelines" come and go.

However, I believe the company anticipated end of October for 100% enrollment.

So... while frustrating, if we knew everything, we wouldn't be on iHub, or wallowing in the gutters of the stock market.

...AKA.. the OTC.

KEEP HOPE ALIVE!

Good Day..Algernaut's!

LS5

Good grief.

How do find your way home at the end of the day?

Thanks med.

Although it may take a couple days for me to decipher/translate, I do understand the gist of it.

Until we see the results in live patients, we will never really know efficacy.

Thank you for the added comments regarding how the neuronal aspects shouldn't be excluded.

If I remember correct from another poster here with credentials way above my pay-grade, Ssbains, who made reference to the same analogy. I believe he opined how Ifenprodil crosses the blood-brain barrier and was created for neuronal indications.

I'm looking at adding some, and looking for some extra motivation. Thank you.

I appreciate the insight.

AGNPF Commencing Countdown.

Good Luck to us all!

LS5

Also, I need to add.

My apologies.. that was an unfair comparison to anyone, let alone Dr. Javitt.

Thank you for the cheat sheet.

Looks like I have a little homework to do.

I'm only a newbie here but I am familiar with what I believe are the mechanisms of action related to COVID-19 that I am interested in.

I will look into any drugs focusing on immune response suppression. Imo it is the key to lung protection, and ultimately, the reason COVID-19 has changed life as we all knew it.

Appreciate the feedback.

LS5

Yes, politics should be avoided. But it should be noted... it does have an effect.

I will take a position here, I'm just thinking there is time before data results in... Spring?

If it spikes, I will be ready.

My only question is... do I play the run-up? Or do I see the potential, and stick around for the blue-sky breakout... potentially.

...Best of luck!

LS5

Thanks for the offer to help with any questions I may have.

Like I said, been associated with expert schemer's. Talk is cheap.

Real results from a double-blind clinical trial are the only thing going to move the sp.

Preliminary results, from the company, are meaningless.

For now, I will wait, do a deeper dive, and report back with any potential questions.

LS5

Hey medchem, I've been a big fan of yours here for years. Well, since I got in back in '17.

It took me 3yrs to figure out how to post, so I just lurked... very creepy, I know. Turned out I never verified my email..lol

Now that we are thru intros.. let's move on.

During your extended absence, many developments have occurred here.

My question, finally, is...

What are your thoughts on the UT Dallas study linking Ifenprodil potential to actual COVID-19 infected lung cells?

Just wondering if you've noticed any other drugs chasing COVID-19 that have "3rd party validation"? (not sure if it qualifies as such).

Or.. if in your research, you've come across any other drugs that were already researching for indications that are COVID-19 related.

Sorry if you have already weighed in, please slap me next time/1st time we meet.

LS5